Computational design of protein binders that boost the antitumour efficacy of CAR T cells

被引：0

作者：

Xia, Zhen ^{[1
]}

Xie, Qi ^{[1
]}

机构：

[1] Westlake Univ, Hangzhou, Peoples R China

来源：

NATURE BIOMEDICAL ENGINEERING | 2024年 / 8卷 / 12期

关键词：

HETEROGENEITY; REVEALS;

D O I：

10.1038/s41551-024-01263-x

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

We computationally designed protein binders for chimeric antigen receptor (CAR) constructs to target the glioblastoma-associated antigens EGFR and CD276. Compared with standard CAR T cells, CAR T cells with the de novo-designed binders showed enhanced proliferation, cytokine release and resistance to exhaustion, as well as superior antitumour effects in vitro and in vivo.

引用

页码：1521 / 1522

页数：2

共 50 条

[41] CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome
Rodriguez-Marquez, Paula
Calleja-Cervantes, Maria Erendira
Serrano, Guillermo
Palacios-Berraquero, Maria Luisa
Alignani, Diego
Martin-Uriz, Patxi San
Vilas-Zornoza, Amaia
Ceballos, Candela
Martin-Mallo, Angel
Rodríguez-Diaz, Saray
Martínez-Turrillas, Rebeca
Jauregui, Patricia
Calviño, Cristina
Inogés, Susana
de Cerio, Ascensión López-Diaz
Oliver-Caldés, Aina
Español-Rego, Marta
Pascal, Mariona
Martin-Antonio, Beatriz
Juan, Manel
Urbano-Ispizua, Alvaro
De Larrea, Carlos Fernández
Viguria, Maria Cruz
Redondo, Ana Margarita
Rodríguez-Otero, Paula
Roca, Jose J. Rifon
Pierola, Ana Alfonso
Lasarte, Juan Jose
Lozano, Teresa
Paiva, Bruno
San-Miguel, Jesús F.
Hernáez, Mikel
Rodriguez-Madoz, Juan Roberto
Prósper, Felipe
BLOOD, 2021, 138
[42] Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Wu, Huantong
Xu, Zhuofan
Qi, Maoyang
Liu, Penghao
Zhang, Boyan
Wang, Zhenglin
Chen, Ge
Liu, Xiaohai
Liu, Junqi
Wei, Wei
Duan, Wanru
Chen, Zan
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
[43] Removing T-cell epitopes with computational protein design
King, Chris
Garza, Esteban N.
Mazor, Ronit
Linehan, Jonathan L.
Pastan, Ira
Pepper, Marion
Baker, David
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (23) : 8577 - 8582
[44] Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches
Ramalingam, Prasanna Srinivasan
Premkumar, T.
Sundararajan, Vino
Hussain, Md Sadique
Arumugam, Sivakumar
DISCOVER ONCOLOGY, 2024, 15 (01)
[45] Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers
Paczesny, Sophie
Pasquini, Marcelo C.
Pavletic, Steven Z.
Agarwal, Amit
Spellman, Stephen
Kean, Leslie
Bernatchez, Chantale
Gust, Juliane
Staedtke, Verena
Perales, Miguel-Angel
BLOOD ADVANCES, 2021, 5 (11) : 2519 - 2522
[46] Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
Smirnov, Sergei
Petukhov, Alexey
Levchuk, Ksenia
Kulemzin, Sergey
Staliarova, Alena
Lepik, Kirill
Shuvalov, Oleg
Zaritskey, Andrey
Daks, Alexandra
Fedorova, Olga
FRONTIERS IN IMMUNOLOGY, 2021, 12
[47] Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
Chen, Qiuqiang
Lu, Lingeng
Ma, Wenxue
CANCERS, 2022, 14 (23)
[48] Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy
Jhaveri, Khushali S.
Schlam, Ilana
Holtzman, Noa G.
Peravali, Monica
Richardson, Perry K.
Dahiya, Saurabh
Malkovska, Vera
Rapoport, Aaron P.
BLOOD ADVANCES, 2020, 4 (23) : 6019 - 6022
[49] Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
Yeku, Oladapo O.
Purdon, Terence J.
Koneru, Mythili
Spriggs, David
Brentjens, Renier J.
SCIENTIFIC REPORTS, 2017, 7
[50] Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
Oladapo O. Yeku
Terence J. Purdon
Mythili Koneru
David Spriggs
Renier J. Brentjens
Scientific Reports, 7

← 1 2 3 4 5 →